Cariprazine Hydrochloride

CAS 1083076-69-0 13 API suppliersSmall Molecule

Overview

Cariprazine Hydrochloride is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. It acts as a partial agonist at D2 and D3 dopamine receptors, providing therapeutic effects on both positive and negative symptoms.

API suppliers (13)

Suppliers of Cariprazine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India6China2Pakistan1Argentina1

Country recorded for 10 of 13 suppliers.

7 of 13 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

PsychiatryBipolar DisorderSchizophrenia
Verified Supplier Partner

Do you supply Cariprazine Hydrochloride? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.